Furthermore, we also found that the frequency of carcinoma in situ among the nodules with other type gene mutation (n = 8, 14.1%) or wildtype gene (n = 28, 25.7%) was higher than those with EGFR mutation (n = 5, 5.1%) (P < 0.001). The gene discussed is EGFR; the disease is in situ carcinoma.